Regulatory NewsTrials & Tribulations Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research October 17, 2025Vol.51 No.38By Edison T. Liu
Trials & Tribulations Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology September 26, 2025Vol.51 No.35By Hardeep Phull
Trials & Tribulations An overlooked immune cell population may offer new direction for cell and gene therapy July 11, 2025Vol.51 No.27By Arthur Machlenkin
Trials & Tribulations As cancer patients use AI chatbots, dangers lurk—but new safeguards can help June 27, 2025Vol.51 No.25By Ghulam Rasool, Brian D. Gonzalez and Katherine Chung-Bridges
Trials & Tribulations Optimizing dosing of expensive and toxic oncology drugs: Making America healthier June 20, 2025Vol.51 No.24By Mark J. Ratain, David A. Hyman, Jill E. Feldman, Beth R. Jacobson and Allen S. Lichter
Trials & Tribulations Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements June 06, 2025Vol.51 No.22By Mecker G. Möller
Trials & Tribulations The other side of the patient portal: Reflections from a cancer center leader May 30, 2025Vol.51 No.21By Ruben A. Mesa
Trials & Tribulations Surviving cancer is often not a patient’s most challenging battle May 30, 2025Vol.51 No.21By Boris C. Pasche
Trials & Tribulations Biden’s diagnosis is unfortunate but—statistically—not surprisingOf the 384 men serving in Congress, 48 are likely to be diagnosed with prostate cancer in their lifetime May 23, 2025Vol.51 No.20By Peter Nelson
Trials & Tribulations Unlocking the future of precision medicine:The untapped power of RNA May 23, 2025Vol.51 No.20By Eric Lefkofsky and Norman E. "Ned" Sharpless
